Alkermes plc. Increase (Decrease) in Contract with Customer, Asset
Alkermes plc. (ALKS) reported Increase (Decrease) in Contract with Customer, Asset of $6.75 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerAsset · last filed 2026-07-28
- Alkermes plc. increase (decrease) in contract with customer, asset for the quarter ending 2025-12-31 was -$717.00K, a 135.48% decline year-over-year.
- Alkermes plc. increase (decrease) in contract with customer, asset for the quarter ending 2025-09-30 was -$707.00K.
- Alkermes plc. increase (decrease) in contract with customer, asset for the quarter ending 2025-06-30 was -$1.63M, a 171.81% decline year-over-year.
- Alkermes plc. increase (decrease) in contract with customer, asset for the quarter ending 2025-03-31 was -$1.94M, a 471.13% decline year-over-year.
- Alkermes plc. increase (decrease) in contract with customer, asset for fiscal 2025 was -$4.99M, a 216.48% decline from fiscal 2024.
- Alkermes plc. increase (decrease) in contract with customer, asset for fiscal 2024 was $4.28M.
- Alkermes plc. increase (decrease) in contract with customer, asset for fiscal 2023 was -$8.22M.
- Alkermes plc. increase (decrease) in contract with customer, asset for fiscal 2022 was -$4.43M.
| Period end | Increase (Decrease) in Contract with Customer, Asset 3 month | Increase (Decrease) in Contract with Customer, Asset 6 month | Increase (Decrease) in Contract with Customer, Asset 9 month | Increase (Decrease) in Contract with Customer, Asset 12 month |
|---|---|---|---|---|
| 2026-06-30 | $6.75M 10-Q · filed 2026-07-28 | |||
| 2025-12-31 | -$717.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$1.42M derived: sum of 2 quarters · filed 2026-02-25 | -$3.05M derived: sum of 3 quarters · filed 2026-07-28 | -$4.99M 10-K · filed 2026-02-25 |
| 2025-09-30 | -$707.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | -$2.33M derived: sum of 2 quarters · filed 2026-07-28 | -$4.27M 10-Q · filed 2025-10-28 | -$2.25M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-06-30 | -$1.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-28 | -$3.57M 10-Q · filed 2026-07-28 | -$1.54M derived: sum of 3 quarters · filed 2026-07-28 | -$2.07M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-03-31 | -$1.94M 10-Q · filed 2026-05-05 | $80.00K derived: sum of 2 quarters · filed 2026-05-05 | -$443.00K derived: sum of 3 quarters · filed 2026-05-05 | $1.82M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $2.02M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $1.50M derived: sum of 2 quarters · filed 2026-02-25 | $3.76M derived: sum of 3 quarters · filed 2026-02-25 | $4.28M 10-K · filed 2026-02-25 |
| 2024-09-30 | -$523.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $1.74M derived: sum of 2 quarters · filed 2025-10-28 | $2.26M 10-Q · filed 2025-10-28 | $203.00K derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $2.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | $2.79M 10-Q · filed 2025-07-29 | $726.00K derived: sum of 3 quarters · filed 2026-02-25 | $3.49M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $523.00K 10-Q · filed 2025-05-01 | -$1.54M derived: sum of 2 quarters · filed 2026-02-25 | $1.23M derived: sum of 3 quarters · filed 2026-02-25 | -$7.20M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | -$2.06M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $706.00K derived: sum of 2 quarters · filed 2026-02-25 | -$7.72M derived: sum of 3 quarters · filed 2026-02-25 | -$8.22M 10-K · filed 2026-02-25 |
| 2023-09-30 | $2.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-24 | -$5.66M derived: sum of 2 quarters · filed 2024-10-24 | -$6.16M 10-Q · filed 2024-10-24 | -$7.34M derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-06-30 | -$8.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-24 | -$8.93M 10-Q · filed 2024-07-24 | -$10.11M derived: sum of 3 quarters · filed 2025-02-12 | -$16.49M derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-03-31 | -$500.00K 10-Q · filed 2024-05-01 | -$1.68M derived: sum of 2 quarters · filed 2025-02-12 | -$8.06M derived: sum of 3 quarters · filed 2025-02-12 | -$11.78M derived: sum of 4 quarters · filed 2025-02-12 |
| 2022-12-31 | -$1.18M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | -$7.56M derived: sum of 2 quarters · filed 2025-02-12 | -$11.28M derived: sum of 3 quarters · filed 2025-02-12 | -$4.43M 10-K · filed 2025-02-12 |
| 2022-09-30 | -$6.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-25 | -$10.11M derived: sum of 2 quarters · filed 2023-10-25 | -$3.26M 10-Q · filed 2023-10-25 | $1.60M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-06-30 | -$3.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-26 | $3.12M 10-Q · filed 2023-07-26 | $7.98M derived: sum of 3 quarters · filed 2024-02-21 | $2.69M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-03-31 | $6.85M 10-Q · filed 2023-04-26 | $11.70M derived: sum of 2 quarters · filed 2024-02-21 | $6.42M derived: sum of 3 quarters · filed 2024-02-21 | $5.93M derived: sum of 4 quarters · filed 2024-02-21 |
| 2021-12-31 | $4.86M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | -$430.00K derived: sum of 2 quarters · filed 2024-02-21 | -$915.00K derived: sum of 3 quarters · filed 2024-02-21 | -$6.04M 10-K · filed 2024-02-21 |
| 2021-09-30 | -$5.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | -$5.77M derived: sum of 2 quarters · filed 2022-11-02 | -$10.89M 10-Q · filed 2022-11-02 | -$10.89M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-06-30 | -$485.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-27 | -$5.61M 10-Q · filed 2022-07-27 | -$5.60M derived: sum of 3 quarters · filed 2023-02-16 | -$446.00K derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-03-31 | -$5.12M 10-Q · filed 2022-04-27 | -$5.12M derived: sum of 2 quarters · filed 2023-02-16 | $39.00K derived: sum of 3 quarters · filed 2023-02-16 | -$4.92M derived: sum of 4 quarters · filed 2023-02-16 |
| 2020-12-31 | $6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $5.16M derived: sum of 2 quarters · filed 2023-02-16 | $202.00K derived: sum of 3 quarters · filed 2023-02-16 | $6.01M 10-K · filed 2023-02-16 |
| 2020-09-30 | $5.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-27 | $196.00K derived: sum of 2 quarters · filed 2021-10-27 | $6.01M 10-Q · filed 2021-10-27 | $14.37M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-06-30 | -$4.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-28 | $854.00K 10-Q · filed 2021-07-28 | $9.22M derived: sum of 3 quarters · filed 2022-02-16 | $1.55M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-03-31 | $5.81M 10-Q · filed 2021-04-28 | $14.18M derived: sum of 2 quarters · filed 2022-02-16 | $6.51M derived: sum of 3 quarters · filed 2022-02-16 | $10.75M derived: sum of 4 quarters · filed 2022-02-16 |
| 2019-12-31 | $8.36M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $696.00K derived: sum of 2 quarters · filed 2022-02-16 | $4.94M derived: sum of 3 quarters · filed 2022-02-16 | $5.16M 10-K · filed 2022-02-16 |
| 2019-09-30 | -$7.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | -$3.42M derived: sum of 2 quarters · filed 2020-10-29 | -$3.21M 10-Q · filed 2020-10-29 | -$8.45M derived: sum of 4 quarters · filed 2021-02-11 |
| 2019-06-30 | $4.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | $4.46M 10-Q · filed 2020-07-29 | -$786.00K derived: sum of 3 quarters · filed 2021-02-11 | -$1.89M derived: sum of 4 quarters · filed 2021-02-11 |
| 2019-03-31 | $217.00K 10-Q · filed 2020-04-29 | -$5.03M derived: sum of 2 quarters · filed 2021-02-11 | -$6.13M derived: sum of 3 quarters · filed 2021-02-11 | -$17.62M derived: sum of 4 quarters · filed 2021-02-11 |
| 2018-12-31 | -$5.25M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11 | -$6.35M derived: sum of 2 quarters · filed 2021-02-11 | -$17.84M derived: sum of 3 quarters · filed 2021-02-11 | -$880.00K 10-K · filed 2021-02-11 |
| 2018-09-30 | -$1.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-23 | -$12.59M derived: sum of 2 quarters · filed 2019-10-23 | $4.37M 10-Q · filed 2019-10-23 | |
| 2018-06-30 | -$11.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-25 | $5.47M 10-Q · filed 2019-07-25 | ||
| 2018-03-31 | $16.96M 10-Q · filed 2019-04-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |